On April 20, 2023, PanGen Biotech Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,760 KRW | -0.52% |
|
-4.23% | -30.81% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
42,800 KRW | +0.59% | +7.54% | 2.77B | ||
5,550 KRW | -1.25% | -3.98% | 369M | ||
4,760 KRW | -0.52% | -4.23% | 39.38M | ||
1st Jan change | Capi. | |
---|---|---|
-30.81% | 39.38M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- A222110 Stock
- News PanGen Biotech Inc.
- PanGen Biotech Inc. announced that it has received KRW 3.2 billion in funding from Eugene Investment & Securities Co.,Ltd., Samsung Securities Co., Ltd.